Skip to content

Consistency of Preoperative MRI-Assessed Tumor Deposits with Pathological Diagnosis and Their Prognostic Significance in Rectal Cancer

Study on the Consistency between Preoperative Imaging Evaluation and Pathological Diagnosis of Tumor Deposits (Cancer Nodules) in Colorectal Cancer and Its Prognostic Value

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109004
Enrollment
Unknown
Registered
2025-09-10
Start date
2025-09-15
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

Gold Standard:The histopathological evaluation: two pathologists assess the nodules identified by CT through the use of an optical microscope on tissue slides stained with hematoxylin and eosin to det
Index test:Preoperative MRI scans to diagnose tumor deposits of patients with rectal cancer.

Sponsors

Department of Gastrointestinal Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age range: Patients must be >= 18 years old; 2. Diagnosed with primary rectal adenocarcinoma by pathological histology; 3. Possess complete pelvic MRI data; 4. Patients who have undergone rectal cancer resection surgery (including those who received treatment before surgery); 5. Patients volunteer to participate in this study, sign a written informed consent form, and agree to cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1. The patient was diagnosed with recurrent tumors, synchrony tumors, familial adenomatous polyposis or inflammatory bowel disease at the time of the visit. 2. MRI cannot be performed or the image quality of imaging data is poor; 3. Have any medical history that may affect compliance with the protocol (such as severe mental disorders, cognitive dysfunction, drug abuse or addiction, etc.); 4. Pregnant or lactating women, or those who are fertile but unwilling or unable to take effective contraceptive measures; 5. Those who have participated in any drug clinical trials within the six months prior to the examination.

Design outcomes

Primary

MeasureTime frame
Accuracy rate;Sensitivity;Specificity;Positive predictive value;Negative predictive value;Receiver Operating Characteristic (ROC) Curve;Degree of consistency;

Secondary

MeasureTime frame
One-year, three-year and five-year survival rates;Hazard Ratio (HR) Estimate;

Countries

China

Contacts

Public ContactMiner Zhong

Department of Gastrointestinal Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China

zhongminer@gdph.org.cn+86 137 1010 8605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026